UBRELVY

This brand name is authorized in Israel, United States

Active ingredients

The drug UBRELVY contains one active pharmaceutical ingredient (API):

1 Ubrogepant
UNII AD0O8X2QJR - UBROGEPANT

Ubrogepant is a calcitonin gene-related peptide (CGRP) receptor antagonist. It is used for the acute treatment of migraine with or without aura in adults.

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
UBRELVY Tablet FDA, National Drug Code (US) MPI, US: SPL/PLR

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 9114, 9115
Country: US FDA, National Drug Code Identifier(s): 0023-6498, 0023-6501

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.